• 1
    Arita, Y., Kihara, S., Ouchi, N., et al (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 257: 7983.
  • 2
    Cnop, M., Havel, P. J., Utzschneider, K. M., et al (2003) Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 46: 459469.
  • 3
    Hotta, K., Funahashi, T., Arita, Y., et al (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 20: 15951599.
  • 4
    Lindsay, R. S., Funahashi, T., Hanson, R. L., et al (2002) Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet. 360: 5758.
  • 5
    Zoccali, C., Mallamaci, F., Tripepi, G., et al (2002) Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol. 13: 134141.
  • 6
    Pischon, T., Girman, C. J., Hotamisligil, G. S., Rifai, N., Hu, F. B., Rimm, EB. (2004) Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 291: 17301737.
  • 7
    Lewis, C. E., Jacobs, D. R. Jr, McCreath, H., et al (2000) Weight gain continues in the 1990s: 10-year trends in weight and overweight from the CARDIA study: Coronary Artery Risk Development in Young Adults. Am J Epidemiol. 151: 11721181.
  • 8
    Steffes, M. W., Gross, M. D., Schreiner, P. J., et al (2004) Serum adiponectin in young adults: interactions with central adiposity, circulating levels of glucose and insulin resistance, the CARDIA Study. Ann Epidemiol. 14: 492498.
  • 9
    The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 157: 24132446.; (1997).
  • 10
    Gross, M., Steffes, M., Jacobs, D. R. Jr, et al (2005) Plasma F2-isoprostanes and coronary artery calcification: the CARDIA Study. Clin Chem. 51: 125131.
  • 11
    Marcovina, S. M., Gaur, V. P., Albers, JJ. (1994) Biological variability of cholesterol, triglyceride, low- and high-density lipoprotein cholesterol, lipoprotein(a), and apolipoproteins A-I and B. Clin Chem. 40: 574578.
  • 12
    Friedewald, W. T., Levy, R. I., Fredrickson, DS. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18: 499502.
  • 13
    Tracy, R. P., Lemaitre, R. N., Psaty, B. M., et al (1997) Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol. 17: 11211127.
  • 14
    Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., Turner, RC. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28: 412419.
  • 15
    Weyer, C., Funahashi, T., Tanaka, S., et al (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 86: 19301935.
  • 16
    Tsao, T. S., Murrey, H. E., Hug, C., Lee, D. H., Lodish, HF. (2002) Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30). J Biol Chem. 277: 2935929362.
  • 17
    Tsao, T. S., Tomas, E., Murrey, H. E., et al (2003) Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity: different oligomers activate different signal transduction pathways. J Biol Chem. 278: 5081050817.
  • 18
    Gopaul, N. K., Anggard, E. E., Mallet, A. I., Betteridge, D. J., Wolff, S. P., Nourooz-Zadeh, J. (1995) Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett. 368: 225229.
  • 19
    Matsuda, M., Shimomura, I., Sata, M., et al (2002) Role of adiponectin in preventing vascular stenosis: the missing link of adipo-vascular axis. J Biol Chem. 277: 3748737491.
  • 20
    Rader, DJ. (2003) Regulation of reverse cholesterol transport and clinical implications. Am J Cardiol. 92: 429J.
  • 21
    Schmitz, G., Kaminski, WE. (2001) ABC transporters and cholesterol metabolism. Front Biosci. 6: D505D514.
  • 22
    Miller, M., Rhyne, J., Hamlette, S., Birnbaum, J., Rodriguez, A. (2003) Genetics of HDL regulation in humans. Curr Opin Lipidol. 14: 273279.